Singapore markets close in 20 minutes
Straits Times Index
3,294.29 +10.35 (+0.32%) Nikkei
27,772.93 +305.70 (+1.11%) Hang Seng
24,952.35 +824.50 (+3.42%) FTSE 100
7,605.29 +15.63 (+0.21%) BTC-USD
41,979.03 +730.13 (+1.77%) CMC Crypto 200
996.68 +1.93 (+0.19%)
Regeneron Pharmaceuticals, Inc. (REGN)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EST
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 72.00B |
| Enterprise value | 68.91B |
| Trailing P/E | 10.72 |
| Forward P/E | 14.39 |
| PEG Ratio (5 yr expected) | 1.21 |
| Price/sales (ttm) | 5.53 |
| Price/book (mrq) | 4.17 |
| Enterprise value/revenue | 5.09 |
| Enterprise value/EBITDA | 8.23 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.17 |
| 52-week change 3 | 14.14% |
| S&P500 52-week change 3 | 18.79% |
| 52-week high 3 | 686.62 |
| 52-week low 3 | 441.00 |
| 50-day moving average 3 | 632.77 |
| 200-day moving average 3 | 584.01 |
Share statistics
| Avg vol (3-month) 3 | 744.41k |
| Avg vol (10-day) 3 | 752.41k |
| Shares outstanding 5 | 105.72M |
| Implied shares outstanding 6 | 107.54M |
| Float 8 | 99.54M |
| % held by insiders 1 | 2.98% |
| % held by institutions 1 | 87.55% |
| Shares short (30 Dec 2021) 4 | 1.64M |
| Short ratio (30 Dec 2021) 4 | 2.17 |
| Short % of float (30 Dec 2021) 4 | 1.83% |
| Short % of shares outstanding (30 Dec 2021) 4 | 1.52% |
| Shares short (prior month 29 Nov 2021) 4 | 1.48M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | N/A |
| Trailing annual dividend yield 3 | N/A |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2020 |
| Most-recent quarter (mrq) | 29 Sep 2021 |
Profitability
| Profit margin | 52.38% |
| Operating margin (ttm) | 53.85% |
Management effectiveness
| Return on assets (ttm) | 22.61% |
| Return on equity (ttm) | 51.09% |
Income statement
| Revenue (ttm) | 13.36B |
| Revenue per share (ttm) | 126.60 |
| Quarterly revenue growth (yoy) | 50.50% |
| Gross profit (ttm) | 4.46B |
| EBITDA | 7.47B |
| Net income avi to common (ttm) | 7B |
| Diluted EPS (ttm) | 62.53 |
| Quarterly earnings growth (yoy) | 93.80% |
Balance sheet
| Total cash (mrq) | 5.79B |
| Total cash per share (mrq) | 55.35 |
| Total debt (mrq) | 2.7B |
| Total debt/equity (mrq) | 15.64 |
| Current ratio (mrq) | 3.71 |
| Book value per share (mrq) | 163.52 |
Cash flow statement
| Operating cash flow (ttm) | 5.94B |
| Levered free cash flow (ttm) | 3.45B |
© 2022 Yahoo. All rights reserved.
